Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Glassia
1.2.3 Aralast NP
1.2.4 Prolastin C
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Perspective (2017-2028)
2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Growth Trends by Region
2.2.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Region (2017-2022)
2.2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028)
2.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Dynamics
2.3.1 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Industry Trends
2.3.2 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
2.3.3 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
2.3.4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue
3.1.1 Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Revenue (2017-2022)
3.1.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue
3.4 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio
3.4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
3.5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Key Players Head office and Area Served
3.6 Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
3.7 Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Type
4.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Type (2017-2022)
4.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028)
5 Alpha-1 Antitrypsin Deficiency Augmentation Therapy Breakdown Data by Application
5.1 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Historic Market Size by Application (2017-2022)
5.2 Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
6.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
6.2.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
6.2.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
6.2.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
6.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
6.3.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
6.3.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
6.3.3 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
6.4 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
6.4.1 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
6.4.2 North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
7.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
7.2.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
7.2.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
7.2.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
7.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
7.3.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
7.3.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
7.3.3 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
7.4 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
7.4.1 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
7.4.2 Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
8.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
8.2.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
8.3.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region
8.4.1 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
9.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
9.2.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
9.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
9.3.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
9.4 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
9.4.1 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (2017-2028)
10.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type
10.2.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application
10.3.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country
10.4.1 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.1.4 Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.1.5 Grifols Recent Developments
11.2 CSL
11.2.1 CSL Company Details
11.2.2 CSL Business Overview
11.2.3 CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.2.4 CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.2.5 CSL Recent Developments
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.3.4 Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.3.5 Baxter Recent Developments
11.4 Kamada
11.4.1 Kamada Company Details
11.4.2 Kamada Business Overview
11.4.3 Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.4.4 Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.4.5 Kamada Recent Developments
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.5.4 Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.5.5 Takeda Recent Developments
11.6 Abeona
11.6.1 Abeona Company Details
11.6.2 Abeona Business Overview
11.6.3 Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Introduction
11.6.4 Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
11.6.5 Abeona Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Glassia
Table 3. Key Players of Aralast NP
Table 4. Key Players of Prolastin C
Table 5. Key Players of Others
Table 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2017-2022)
Table 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region (2023-2028)
Table 12. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Trends
Table 13. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Drivers
Table 14. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Challenges
Table 15. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Restraints
Table 16. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Players (2017-2022)
Table 18. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
Table 19. Ranking of Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product Solution and Service
Table 23. Date of Enter into Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2017-2022)
Table 27. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Market Share by Type (2023-2028)
Table 29. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Application (2017-2022)
Table 31. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue Share by Application (2023-2028)
Table 33. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 63. Grifols Company Details
Table 64. Grifols Business Overview
Table 65. Grifols Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 66. Grifols Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 67. Grifols Recent Developments
Table 68. CSL Company Details
Table 69. CSL Business Overview
Table 70. CSL Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 71. CSL Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 72. CSL Recent Developments
Table 73. Baxter Company Details
Table 74. Baxter Business Overview
Table 75. Baxter Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 76. Baxter Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 77. Baxter Recent Developments
Table 78. Kamada Company Details
Table 79. Kamada Business Overview
Table 80. Kamada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 81. Kamada Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 82. Kamada Recent Developments
Table 83. Takeda Company Details
Table 84. Takeda Business Overview
Table 85. Takeda Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 86. Takeda Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 87. Takeda Recent Developments
Table 88. Abeona Company Details
Table 89. Abeona Business Overview
Table 90. Abeona Alpha-1 Antitrypsin Deficiency Augmentation Therapy Product
Table 91. Abeona Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022) & (US$ Million)
Table 92. Abeona Recent Developments
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Type: 2021 VS 2028
Figure 2. Glassia Features
Figure 3. Aralast NP Features
Figure 4. Prolastin C Features
Figure 5. Others Features
Figure 6. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Application: 2021 VS 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Report Years Considered
Figure 10. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Region: 2021 VS 2028
Figure 13. Global Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Share by Players in 2021
Figure 14. Global Top Alpha-1 Antitrypsin Deficiency Augmentation Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-1 Antitrypsin Deficiency Augmentation Therapy as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Deficiency Augmentation Therapy Revenue in 2021
Figure 16. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 18. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 19. North America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 20. United States Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 24. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 25. Europe Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 26. Germany Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Region (2017-2028)
Figure 36. China Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 46. Mexico Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size Share by Country (2017-2028)
Figure 52. Turkey Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Alpha-1 Antitrypsin Deficiency Augmentation Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Grifols Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 56. CSL Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 57. Baxter Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 58. Kamada Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 59. Takeda Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 60. Abeona Revenue Growth Rate in Alpha-1 Antitrypsin Deficiency Augmentation Therapy Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
